
No results matched your search
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Neutral | Strong Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Evening Doji Star | 15 | Current | |||
Evening Star | 15 | Current | |||
Belt Hold Bearish | 30 | Current | |||
Engulfing Bearish | 30 | Current | |||
Completed Patterns | |||||
Bullish doji Star | 1M | 1 | Jan 21 | ||
Three Inside Up | 1D | 1 | Feb 25, 2021 | ||
Doji Star Bearish | 15 | 2 | Feb 26, 2021 17:00 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 25.45 | 25.90 | 25.30 | -0.40 | -1.55% | 26.61M | 26/02 | ||
Dangote Cement | 207.40 | 207.40 | 207.40 | -12.60 | -5.73% | 174.98K | 26/02 | ||
Guaranty Trust Bank | 31.00 | 31.10 | 31.00 | -0.05 | -0.16% | 9.02M | 26/02 | ||
UBA | 8.15 | 8.35 | 8.00 | -0.05 | -0.61% | 16.09M | 26/02 | ||
Access Bank | 8.25 | 8.25 | 7.95 | +0.15 | +1.85% | 12.38M | 26/02 | ||
Courteville | 0.21 | 0.21 | 0.20 | +0.01 | +5.00% | 1.37M | 26/02 | ||
Sterling Bank | 1.700 | 1.710 | 1.710 | -0.020 | -1.16% | 1.29M | 26/02 | ||
Lafarge Africa | 23.00 | 23.20 | 23.00 | -0.70 | -2.94% | 3.36M | 26/02 | ||
Nestle Nigeria | 1,305.00 | 1,305.00 | 1,305.00 | -145.00 | -10.00% | 32.65K | 26/02 | ||
Nigerian Breweries | 48.00 | 48.00 | 48.00 | -4.00 | -7.69% | 477.09K | 26/02 |
InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development. The Company's drug candidate is cobitolimod that helps in ulcerative colitis treatment. In addition, the Company develops a platform of patent protected substances, DNA based ImmunoModulatory Sequences (DIMS), that helps in the treatment of various immunological diseases. The Company also offers diagnostic kit DiBiCol, which is a PCR-based method that monitors seven biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy. InDex Pharmaceuticals Holding AB operates as a parent for InDex Pharmaceuticals AB and InDex Diagnostics AB. Among the Company's shareholders are SEB Venture Capital, Industrifonden and NeoMed Management.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review